Caroline Rynn

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Oxide Nanoparticles

Metastatic Colorectal Cancer

Induced Pluripotent Stem Cells

Top Venues

Xenobiotica; the fate of foreign compounds in biological systems

Clinical cancer research : an official journal of the American Association for Cancer Research

Pharmaceutical research

This page only lists publications with an associated author ORCID identifier.

Publications

Caroline Rynn, Heide Marika Duevel
Meeting report: DMPK optimisation strategies and quantitative translational PKPD frameworks to predict human PK and efficacious dose of targeted protein degraders. Xenobiotica; the fate of foreign compounds in biological systems (2024)
Caroline Rynn, Heide Marika Duevel
Meeting report: DMPK optimisation strategies and quantitative translational PKPD frameworks to predict human PK and efficacious dose of Targeted protein degraders. Xenobiotica; the fate of foreign compounds in biological systems (2024)
Katja Heinig, Filippo Sladojevich, Jeannine Petrig Schaffland, Georg Jaeschke, Alfred Ross, Philipp Koldewey, Saša M Miladinović, Jin Wang, Caroline Rynn
Chemical, Analytical and Pharmacokinetic Characterisation of RO7304898, an API Consisting of Two Rapidly Interconverting Diastereoisomers. Pharmaceutical research 39 (4) (2022)
Caroline Rynn, Kenichi Umehara, Tianyi Jiang, Malika Ait-Goughoulte, Neil Parrott
A translational strategy employing physiologically based modeling to predict the pharmacological active dose of RO7119929, an oral prodrug of a targeted cancer immunotherapy TLR7 agonist. Xenobiotica; the fate of foreign compounds in biological systems (2022)
Jürgen Wichmann, Caroline Rynn, Thomas Friess, Jeannine Petrig-Schaffland, Martin Kornacker, Cornelia Handl, Jasmin Emmenegger, Jan Eckmann, Frank Herting, Nicolas Frances, Daniel Hunziker, Daniela Krummenacher, Dominik Rüttinger, Alison Ribeiro, Marina Bacac, Alessandro Brigo, David S Hewings, Reinhard Dummer, Mitchell P Levesque, Gabriel Schnetzler, Bruno Martoglio, James R Bischoff, Piergiorgio Pettazzoni
Preclinical characterization of a next generation brain permeable, paradox breaker BRAF inhibitor. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)